FDA shuffles top drug, biologics leaders in latest shakeup
RSS SUMMARY · AGGREGATED FROM CNBC
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
The U.S. Food and Drug Administration is shuffling its top drug and biologics regulators, days after the departure of former commissioner Marty Makary.
Continue Reading
The full story continues on CNBC.
Story Sentry shows a short summary aggregated via RSS. The complete article — original photography, charts, and reporting — lives with the publisher.
The Source
CNBC
US
Elon Musk’s net worth poised to sail past $1 trillion in SpaceX IPO
CNBC·40m ago·3 min read
US
Broadcom stock slips on disappointing software revenue
CNBC·3h ago·3 min read
US
Senate GOP strips up to $1B for Trump ballroom security from immigration enforcement bill
CNBC·3h ago·3 min read
Business
As Honeywell Aerospace readies for its standalone debut, its CEO is forecasting big growth
CNBC·3h ago·3 min read
Related
On this beat
Health
An Uncertain Path for Americans Exposed to Ebola
TNYT·3h ago·3 min read
Health
Autism therapy has attracted predatory providers who bill for phantom services, pad hours and charge steep fees for care delivered by low-paid workers. Here are five takeaways from a WSJ investigation
TWSJ·7h ago·3 min read
Health
New research could help doctors tweak anesthesia to more resemble natural sleep, reducing risks
TWSJ·8h ago·3 min read
Health
Diets high in ultraprocessed foods are associated with an increased risk of dementia, a new study says, adding to the list of health problems linked to foods such as cookies, hot dogs and pizza
TWSJ·14h ago·3 min read